» Articles » PMID: 22162230

Epidemiology and Potential Mechanisms of Tobacco Smoking and Heavy Alcohol Consumption in Pancreatic Cancer

Overview
Journal Mol Carcinog
Date 2011 Dec 14
PMID 22162230
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Tobacco smoking represents an important known cause of ductal pancreatic adenocarcinoma. Recent data from pooled analyses in consortia involving multiple case-control and cohort studies suggest that heavy (but not moderate or light) alcohol consumption also may increase pancreatic cancer risk. Animal and human evidence indicate that tobacco carcinogens and metabolites may act in concert and have both genetic and epigenetic effects at early and later stages in pancreatic tumorigenesis. One of the more important tobacco-related carcinogens, NNK, probably acts via multiple pathways. Heavy alcohol consumption may increase pancreatic cancer risk by potentiating the effects of other risk factors such as tobacco smoking, poor nutrition, and inflammatory pathways related to chronic pancreatitis, but also may have independent genetic and epigenetic effects. Animal and human studies of tobacco- and alcohol-related pancreatic carcinogenesis suggest multi-modal, overlapping mechanistic pathways. Tobacco smoking and heavy alcohol consumption are preventable exposures, and their avoidance would substantially decrease the burden of pancreatic cancer worldwide.

Citing Articles

Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies.

Bouajila N, Domenighetti C, Aubin H, Naassila M Front Epidemiol. 2024; 4:1385064.

PMID: 39574800 PMC: 11578756. DOI: 10.3389/fepid.2024.1385064.


Pancreatic Cancer: A Review of Risk Factors.

Grigorescu R, Husar-Sburlan I, Gheorghe C Life (Basel). 2024; 14(8).

PMID: 39202722 PMC: 11355429. DOI: 10.3390/life14080980.


Association of genetic risk and lifestyle with pancreatic cancer and their age dependency: a large prospective cohort study in the UK Biobank.

Zeng L, Wu Z, Yang J, Zhou Y, Chen R BMC Med. 2023; 21(1):489.

PMID: 38066552 PMC: 10709905. DOI: 10.1186/s12916-023-03202-0.


The Link between Diabetes, Pancreatic Tumors, and miRNAs-New Players for Diagnosis and Therapy?.

Kozlowska M, Sliwinska A Int J Mol Sci. 2023; 24(12).

PMID: 37373398 PMC: 10299694. DOI: 10.3390/ijms241210252.


Brain deficit patterns of metabolic illnesses overlap with those for major depressive disorder: A new metric of brain metabolic disease.

Hatch K, Gao S, Ma Y, Russo A, Jahanshad N, Thompson P Hum Brain Mapp. 2023; 44(6):2636-2653.

PMID: 36799565 PMC: 10028678. DOI: 10.1002/hbm.26235.